<DOC>
	<DOCNO>NCT02603159</DOCNO>
	<brief_summary>Definitive chemoradiotherapy cisplatin cisplatin plus 5-fluorouracil standard Western country esophagus cancer.But China toxic reaction , patient stop halfway.Because low toxicity , Capecitabine widely use chemotherapy esophageal cancer . The purpose experiment study different cycle capecitabine chemotherapy esophageal cancer chemoradiation effect.We prepare within 2 year study recruit 200 patient esophageal cancer.The primary endpoint overall survival secondary endpoint include progression-free survival , response rate , pathologic complete response rate adverse event .</brief_summary>
	<brief_title>Different Cycles Capecitabine Usage Esophageal Cancer Concurrent Chemoradiotherapy</brief_title>
	<detailed_description>We recruit patient pathologically confirm esophageal squamous cell carcinoma Oct 2014 . The patient divide two group . Group 1 : Capecitabine + chemoradiation , radiation end stop use capecitabine . Group 2 : Capecitabine + chemoradiation , end radiotherapy capecitabine consolidate treatment 5 week .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>age 4575years old Histologically proven squamous cell carcinoma esophagus tumor T24N02M0 The patient receive surgery chemoradiotherapy . Hb≥80g/L , absolute neutrophil count ≥1.5×109/L , Plt≥90×109/L , ALT、AST≤2.5*N , Cr≤1.5*N. performance status score 02 pregnant , lactate woman Oxaliplatin fluorouracil Allergy metabolic disorder Radiotherapy contraindication History organ transplantation Brain metastasis The peripheral nervous system disorder Severe infection Oral capecitabine difficulty , dysphagia , The activity digestive ulcer , Gastrointestinal bleeding Severe chronic disease , , hepatopathy , nephropathy , respiratory disease , high blood pressure , diabetes . Other malignant tumor recent 5 year .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Chemoradiotherapy</keyword>
	<keyword>Esophageal Squamous Cancer</keyword>
	<keyword>Capecitabine</keyword>
</DOC>